<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885790</url>
  </required_header>
  <id_info>
    <org_study_id>bakircaymzeren03</org_study_id>
    <nct_id>NCT04885790</nct_id>
  </id_info>
  <brief_title>Investigation of Dynamic Hyperinflation and Its Relationship With Functional Exercise Capacity in Children With Bronchiectasis</brief_title>
  <official_title>Investigation of Dynamic Hyperinflation and Its Relationship With Functional Exercise Capacity in Children With Bronchiectasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Izmir Bakircay University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ege University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Izmir Bakircay University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prevalence of dynamic hyperinflation and its relationship with functional exercise capacity&#xD;
      will be evaluated in children with bronchiectasis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Exercise or hyperpnea-induced air trapping is referred to as dynamic hyperinflation. In the&#xD;
      presence of high resistance to expiratory flows and short expiratory times, the respiratory&#xD;
      system is unable to return to its resting volume at the end of exhalation. The positive&#xD;
      pressure within regions of hyperinflated lung raises the mean intrathoracic pressure and&#xD;
      causes the inspiratory muscles to operate at a higher than resting lung volume. Thus, dynamic&#xD;
      hyperinflation places the respiratory muscles at a considerable mechanical disadvantage and&#xD;
      further impairs respiratory function. Dynamic hyperinflation is considered to be a key&#xD;
      determinant of exercise capacity in patients with obstructive lung diseases. Although&#xD;
      bronchiectasis is one of the obstructive lung diseases, the presence of dynamic&#xD;
      hyperinflation in these patients has not been adequately investigated. Management guidelines&#xD;
      of bronchiectasis state that imaging methods or pulmonary function tests alone is not&#xD;
      sufficient to determine the disease burden and prognosis in these patients, so they recommend&#xD;
      including detailed evaluation of exercise tolerance in the management of bronchiectasis. Aim&#xD;
      of this study is to investigate the prevalence of dynamic hyperinflation and its relationship&#xD;
      with functional exercise capacity in children with bronchiectasis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Actual">August 10, 2021</completion_date>
  <primary_completion_date type="Actual">August 10, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dynamic hyperinflation</measure>
    <time_frame>At baseline</time_frame>
    <description>Dynamic hyperinflation will be defined as a decrease of &gt;100 mL in inspiratory capacity at the end of six-minute walk test determined by Spiropalm 6MWT device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk distance</measure>
    <time_frame>At baseline</time_frame>
    <description>Distance walked in six minutes will be recorded. Test will be conducted according to the guideline of American Thoracic Society.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minute ventilation</measure>
    <time_frame>At baseline</time_frame>
    <description>Maximum minute ventilation during six-minute walk test will be measured via Spiropalm 6MWT device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breathing reserve</measure>
    <time_frame>At baseline</time_frame>
    <description>Breathing reserve (BR) will be calculated as the difference between the maximal voluntary ventilation (MVV) and the maximum minute ventilation (VE) as a fraction of the MVV using Spiropalm 6MWT during six-minute walk test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced Vital Capacity (FVC)</measure>
    <time_frame>At baseline</time_frame>
    <description>FVC will be measured before six-minute walk test according to the guideline of European Respiratory Society.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced Expiratory Volume in 1 second (FEV1)</measure>
    <time_frame>At baseline</time_frame>
    <description>FEV1 will be measured before six-minute walk test according to the guideline of European Respiratory Society.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Expiratory Flow (PEF)</measure>
    <time_frame>At baseline</time_frame>
    <description>PEF will be measured before six-minute walk test according to the guideline of European Respiratory Society.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handgrip strength</measure>
    <time_frame>At baseline</time_frame>
    <description>Handgrip strength will be measured using handgrip dynamometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>M. Quadriceps strength</measure>
    <time_frame>At baseline</time_frame>
    <description>M. Quadriceps strength will be measured using hand-held dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leicester Cough Questionnaire</measure>
    <time_frame>At baseline</time_frame>
    <description>Chronic cough will be evaluated using Leicester Cough Questionnaire. Questionnaire consists of 19 items covering physical, psychological and social domains with a 7 point likert response scale (range from 1 to 7). Higher score indicates better quality of life.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Bronchiectasis</condition>
  <arm_group>
    <arm_group_label>Bronchiectasis</arm_group_label>
    <description>Children with bronchiectasis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Respiratory assessment using &quot;Spiropalm 6MWT&quot; portable spirometry</intervention_name>
    <description>&quot;Spiropalm 6MWT&quot; portable spirometry will be used during six-minute walk test for evaluation of dynamic hyperinflation and other related ventilatory parameters. The device will also be used as regular spirometry.</description>
    <arm_group_label>Bronchiectasis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evaluation of functional exercise capacity</intervention_name>
    <description>Functional exercise capacity of patients will be evaluated using six-minute walk test.</description>
    <arm_group_label>Bronchiectasis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evaluation of peripheral muscle strength</intervention_name>
    <description>Handgrip strength and M. Quadriceps strength will be evaluated using hand-held dynamometer.</description>
    <arm_group_label>Bronchiectasis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evaluation of chronic cough</intervention_name>
    <description>The Leicester Cough Questionnaire will be used for evaluating cough.</description>
    <arm_group_label>Bronchiectasis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with bronchiectasis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of bronchiectasis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hospitalization history during past month&#xD;
&#xD;
          -  Diagnosis of any other chronic childhood diseases such as cerebral palsy or&#xD;
             neuromuscular diseases which may impede exercise tolerance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Ege University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Pulmonology</name>
      <address>
        <city>Ä°zmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 8, 2021</study_first_submitted>
  <study_first_submitted_qc>May 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Izmir Bakircay University</investigator_affiliation>
    <investigator_full_name>Melih Zeren</investigator_full_name>
    <investigator_title>Assist. Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>bronchiectasis</keyword>
  <keyword>children</keyword>
  <keyword>dynamic hyperinflation</keyword>
  <keyword>exercise capacity</keyword>
  <keyword>pulmonary function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

